Company profile
DB · companies + sec_company_profileCharles River Laboratories International, Inc. (CRL) — the SEC company profile (description, website, HQ) has not been loaded for this ticker yet. Run the SEC profile loader to populate it.
AI description
Arphra AILoading cached description…
Identifiers
- SymbolCRL
- Legal nameCharles River Laboratories International, Inc.
- SectorHealthcare
- IndustryMedical - Diagnostics & Research
- CountryUS
- CurrencyUSD
- ExchangeNYSE
- CIK0001100682
- ISIN—
- CUSIP—
- LEI—
- Employees—
Trading
DB · key_metrics_ttmMay 02, 2026- Market cap$8.18B
- P/E (TTM)—
- P/B—
- EV / EBITDA—
- Dividend yield—
Identifiers
OpenFIGI · GLEIFCross-source keys used to bridge FMP, SEC, and non-US data.
- FIGIBBG000BG5BL8
- CountryUSA
Key executives
DB · executives| Name | Title | Compensation | Born | Since |
|---|---|---|---|---|
| James C. Foster | Chairman, President & Chief Executive Officer | $3.83M | 1951 | — |
| Birgit Girshick | Corporate Executive Vice President & Chief Operating Officer | $1.77M | 1970 | — |
| Joseph W. LaPlume | Corporate Executive Vice President of Corporate Development & Strategy | $1.25M | 1974 | — |
| Victoria L. Creamer | Corporate Executive Vice President & Chief People Officer | $1.23M | 1970 | — |
| Glenn G. Coleman | Corporate Executive Vice President & Chief Financial Officer | $930.2K | 1968 | — |
| Michael Gunnar Knell | Corporate Senior Vice President & Chief Accounting Officer | $912.23K | 1977 | — |
| Todd Spencer | Corporate Vice President of Investor Relations | — | — | — |
| Julie Frearson | Corporate Senior Vice President & Chief Scientific Officer | — | — | — |